[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CurrentPartnering: Market Research Reports

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Publications found: 71
Sort by:
Global Companion Diagnostics Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Companion Diagnostics deals Access to Companion Diagnostics contract documents Leading Companion Diagnostics deals by value since 2014 Most active Companion Diagnostics dealmakers since 2014 In Global Companion Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

November 2020 300 pages
Global Cancer Vaccine Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...

November 2020 250 pages
Global Antibody Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... announced in the healthcare sectors, covering: Antibodies Antibody-drug conjugates Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Polyclonal Antibodies Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process ...

November 2020 950 pages
Global Infectious Diseases Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION Global Infectious Diseases Partnering 2014 to 2019 provides the full collection of Infectious Diseases disease deals signed between ...

November 2020 1400 pages
Global Metabolic Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Metabolic Partnering 2014 to 2019 provides the full collection of Metabolic disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Metabolic partnering deals Financial deal terms ...

November 2020 650 pages
Global Musculoskeletal Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Musculoskeletal Partnering 2014 to 2019 provides the full collection of Musculoskeletal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Musculoskeletal partnering deals Financial deal terms ...

November 2020 400 pages
Global Oncology Partnering 2015-2020: Deal trends, players and financials US$ 3,495.00

... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...

November 2020 2600 pages
Global Antibiotics Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...

November 2020 250 pages
Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

November 2020 500 pages
Global Orphan Diseases Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... to hundreds of Orphan Diseases deal contract documents Comprehensive access to over 120 Orphan Diseases deal records The leading Orphan Diseases deals by value since 2014 Most active Orphan Diseases dealmakers since 2014 In Global Orphan Diseases Partnering 2014 to 2019, available deals and ...

November 2020 200 pages
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... cancer monoclonal antibody deals by value since 2014 In Cancer Monoclonal Antibody Partnering Terms & Agreements, the available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific oncology ...

November 2020 350 pages
Global Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... healthcare sectors, covering: Companion Diagnostics Imaging CT Endoscope Molecular and nuclear MRI Ultrasound X-ray PET SPECT Angiography Fluroscopy Mammography In vitro diagnostics Molecular diagnostics Prognostics Theranostics The report provides a detailed ...

November 2020 1450 pages
Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials US$ 3,495.00

... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...

November 2020 500 pages
Global Drug Delivery Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... Drug Delivery deals Access to Drug Delivery contract documents Leading Drug Delivery deals by value since 2014 Most active Drug Delivery dealmakers since 2014 In Global Drug Delivery Partnering 2014-2019: Deal ... at signing Deal component type Specific therapy target Technology type Each deal title links ...

November 2020 750 pages
Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2020: Deal trends, players and financials US$ 3,495.00

... 250 infectious vaccines deal records Identify the most active infectious vaccine dealmakers since 2014 The leading infectious vaccines deals by value since 2014 Includes adjuvant deals and alliances since 2014 In Global Infectious Vaccines Partnering Terms ...

November 2020 350 pages
Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... of real-life In Vitro Diagnostics deals Access to In Vitro Diagnostics contract documents Leading In Vitro Diagnostics deals by value since 2014 Most active In Vitro Diagnostics dealmakers since 2014 In Global In Vitro Diagnostics Partnering 2014-2019: Deal trends, players ...

November 2020 350 pages
Global Stem Cell Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Stem Cell deals Access to Stem Cell contract documents Leading Stem Cell deals by value since 2014 Most active Stem Cell dealmakers since 2014 In Global Stem Cell Partnering 2014-2019: Deal trends, players, financials and ...

November 2020 450 pages
Global Artificial Intelligence (AI) Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... 200 artificial intelligence deals The leading artificial intelligence deals by value since 2014 Most active artificial intelligence dealmakers since 2014 The leading artificial intelligence partnering resources In Global Artificial Intelligence Partnering Terms and ...

November 2020 250 pages
Global Precision Medicine Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding ...

November 2020 700 pages
Global COVID-19 Partnering - 12 month subscription US$ 2,495.00

SUMMARY The Global COVID-19 Partnering report provides comprehensive understanding and unprecedented access to the COVID-19 partnering deals and agreements entered into by the worlds leading healthca...

November 2020 450 pages
Global Biomarker Partnering Terms and Agreements 2014-2020: Deal trends, players and financials US$ 3,495.00

SUMMARY The Global Biomarker Partnering Terms and Agreements 2014-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partn...

November 2020 350 pages
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies REPORT SCOPE Global Asset Purchase Deals in Pharma, Biotech and ...

October 2020 650 pages
Global Cardiovascular Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...

October 2020 500 pages
Global Central Nervous System Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig ...

October 2020 950 pages
Global Dental Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Dental Partnering 2014 to 2019 provides the full collection of Dental disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Dental partnering deals Financial deal terms ...

October 2020 200 pages
Global Gastrointestinal Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... , Esophagitis, Gastritis, Gastroenteritis, Hemorrhoids (haemorrhoids), Hernia, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Irritable bowel syndrome, Malabsorption, Malnutrition, Pancreatitis, Peptic ulce, Gastric ulcer, Duodenal ulcer, Abdominal pain, Ascites, Bowel movement, Constipation ...

October 2020 300 pages
Global Dermatology Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...

October 2020 400 pages
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... manufacturing and supply deals by value since 2014 Most active manufacturing and supply dealmakers since 2014 The leading manufacturing and supply partnering resources In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech ...

October 2020 1100 pages
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... Current Agreements deals and alliances database, providing easy access to each deal record on demand. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 ...

October 2020 300 pages
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

October 2020 450 pages
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

October 2020 2800 pages
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...

October 2020 1100 pages
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...

October 2020 300 pages
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...

October 2020 2400 pages
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

October 2020 850 pages
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020 US$ 3,495.00

... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...

October 2020 450 pages
Global Autoimmune Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Glomerulonephritis, Endometriosis, Immune thrombocytopenic purpura, Neutropenia, Graft versus host disease, Scleroderma ...

October 2020 650 pages
Global Psychiatry Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Psychiatry Partnering 2014 to 2019 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Psychiatry partnering deals Financial deal terms ...

September 2020 500 pages
Global Respiratory Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Respiratory Partnering 2014 to 2019 provides the full collection of Respiratory disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Respiratory partnering deals Financial deal terms ...

September 2020 550 pages
Global Pediatrics Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... to hundreds of Pediatrics deal contract documents Comprehensive access to over 200 Pediatrics deal records The leading Pediatrics deals by value since 2014 Most active Pediatrics dealmakers since 2014 In Global Pediatrics Partnering 2014 to 2019, available deals and ...

September 2020 450 pages
Global Ophthalmics Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Ophthalmics Partnering 2014 to 2019 provides the full collection of Ophthalmics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Ophthalmics partnering deals Financial deal terms ...

September 2020 350 pages
Global Public Health Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... access to Public Health trends and structure of deals entered into by leading companies worldwide. Global Public Health Partnering 2014 to 2019 includes: Trends in Public Health dealmaking in the biopharma industry since 2014 Analysis of Public Health deal structure ...

September 2020 350 pages
Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020 US$ 3,495.00

... 1,700 clinical stage deals The leading clinical stage deals by value since 2014 Most active clinical stage dealmakers since 2014 The leading clinical stage partnering resources In Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014 ...

September 2020 1600 pages
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2020 US$ 3,495.00

... 2,000 discovery stage deals The leading discovery stage deals by value since 2014 Most active discovery stage dealmakers since 2014 The leading discovery stage partnering 2014 In Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014 ...

September 2020 2000 pages
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2020 US$ 3,495.00

... 1,200 preclinical stage deals The leading preclinical stage deals by value since 2014 Most active preclinical stage dealmakers since 2014 The leading preclinical stage partnering resources In Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014 ...

September 2020 1300 pages
Global Academic and Non-Profit Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... Academic and Non-Profit deals Access to Academic and Non-Profit contract documents Leading Academic and Non-Profit deals by value since 2014 Most active Academic and Non-Profit dealmakers since 2014 In Global Academic and Non-Profit Partnering ...

September 2020 3000 pages
Global Animal Health Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... access to actual Animal Health contracts entered into by leading biopharma companies Identify most active Animal Health dealmakers since 2014 Insight into terms included in a Animal Health partnering agreement, with real ...

September 2020 350 pages
Global Big Pharma Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... an agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 25 most active companies including Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson & Johnson ...

September 2020 1400 pages
Global Biotech Partnering Terms and Agreements 2016-2020 US$ 3,495.00

SUMMARY Global Biotech Partnering Terms and Agreements 2014 to 2019 report provides a detailed understanding and analysis of how and why companies enter Biotech partnering deals DESCRIPTION Global Biotech Partnering Terms and Agreements 2014 ...

September 2020 2900 pages
Global Medical Device Partnering Terms and Agreements 2014-2020 US$ 3,495.00

SUMMARY Global Medical Device Partnering Terms and Agreements 2014-2019 report provides a detailed understanding and analysis of how and why companies enter Medical Device partnering deals DESCRIPTION Global Medical Device Partnering Terms and Agreements 2014 ...

September 2020 1300 pages

Filters

Search

Categories

7
4
2
1
1
1
1
1
2
1
1
1
1
1
25
20
1

Publishers

71

Regions

71

Price

Date

Pages

Offers